Skip to main content
. 2022 Jan 21;13:811952. doi: 10.3389/fimmu.2022.811952

Table 4.

The accuracy of the model to distinguish severity groups 2b and 3 from severity groups 1 and 2a in the cases of breakthrough infection.

A. Clinical data alone
Day True Severity Estimated S1 (n) estimate S2a, 2b, 3 (n) Error Rate Accuracy
day 4-7 S1, 2a (n) 6 0 0.00 0.67
S2b, 3 (n) 3 0 1.00
day 5-8 S1, 2a (n) 4 1 0.20 0.60
S2b, 3 (n) 3 2 0.60
day 6-9 S1, 2a (n) 3 1 0.25 0.56
S2b, 3 (n) 3 2 0.60
day 7-10 S1, 2a (n) 1 2 0.67 0.50
S2b, 3 (n) 2 3 0.40
day 8-11 S1, 2a (n) 3 2 0.40 0.45
S2b, 3 (n) 4 2 0.67
day 9-12 S1, 2a (n) 3 2 0.40 0.60
S2b, 3 (n) 2 3 0.40
B. Clinical data + antibody data
Day True Severity Estimated S1 (n) Estimate S2a, 2b, 3 (n) Error Rate (%) Accuracy
day 4-7 S1, 2a (n) 6 0 0.00 0.67
S2b, 3 (n) 3 0 1.00
day 5-8 S1, 2a (n) 5 0 0.00 0.50
S2b, 3 (n) 5 0 1.00
day 6-9 S1, 2a (n) 4 0 0.00 0.44
S2b, 3 (n) 5 0 1.00
day 7-10 S1, 2a (n) 3 0 0.00 0.38
S2b, 3 (n) 5 0 1.00
day 8-11 S1, 2a (n) 5 0 0.00 0.45
S2b, 3 (n) 6 0 1.00
day 9-12 S1, 2a (n) 3 2 0.40 0.50
S2b, 3 (n) 3 2 0.60